In COPD, this includes increases in ET-1 and Gal-3 during exacerbations, gradual decline in eGFR, rising albuminuria, and CT-documented progression of emphysema [14,15,16,17,18]. This evidence concerns the gene LGALS3 and chronic obstructive pulmonary disease.